Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
VASOTEC
Generic name / active ingredient
enalapril maleate
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-28

Copy from the pack in hand

Source-linked reading points

  • Check VASOTEC, enalapril maleate, oral tablet, 2.5/5/10/20 mg, NDC, imprint and target market together. Do not treat enalaprilat injection, an enalapril/hydrochlorothiazide combination, lisinopril, captopril or an ARB as the same product.
  • 2.5, 5, 10 and 20 mg each state a labelled amount per tablet. Individual use also depends on the prescription, blood pressure, kidney function, potassium, age, volume status and other medicines; the site cannot convert a strength into a tablet count or daily total.
  • A score in the label does not mean everyone should split the tablet or that another manufacturer's enalapril score has the same purpose. Check the exact product, prescription and current label in hand, then confirm with a pharmacist or prescriber.
  • Place diuretics, potassium supplements, potassium-containing salt substitutes, NSAIDs such as ibuprofen/naproxen, lithium, other ACE inhibitors, ARBs and sacubitril/valsartan on one list for review. Do not self-combine, separate, alternate by day, stop or substitute.

Reviewed presentation examples — compare every field

  • Enalapril maleate 2.5 mg per tablet; NDC 0187-0140-30; 30-tablet bottleNDC 0187-0140-30
  • Enalapril maleate 5 mg per tablet; NDC 0187-0141-30; 30-tablet bottleNDC 0187-0141-30
  • Enalapril maleate 10 mg per tablet; NDC 0187-0142-30; 30-tablet bottleNDC 0187-0142-30
  • Enalapril maleate 20 mg per tablet; NDC 0187-0143-30; 30-tablet bottleNDC 0187-0143-30

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-28
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image